1. Home
  2. ICCC vs SRZN Comparison

ICCC vs SRZN Comparison

Compare ICCC & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$10.02

Market Cap

75.8M

Sector

Health Care

ML Signal

HOLD

Logo Surrozen Inc.

SRZN

Surrozen Inc.

HOLD

Current Price

$27.30

Market Cap

356.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
SRZN
Founded
1982
2015
Country
United States
United States
Employees
N/A
44
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.8M
356.0M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ICCC
SRZN
Price
$10.02
$27.30
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.00
AVG Volume (30 Days)
28.0K
81.3K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
0.21
N/A
Revenue
$26,493,169.00
N/A
Revenue This Year
N/A
$75.35
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
51.64
N/A
52 Week Low
$4.52
$7.45
52 Week High
$10.25
$35.00

Technical Indicators

Market Signals
Indicator
ICCC
SRZN
Relative Strength Index (RSI) 73.69 41.16
Support Level $5.85 $23.95
Resistance Level N/A $29.18
Average True Range (ATR) 0.50 2.24
MACD 0.12 -0.61
Stochastic Oscillator 97.37 14.70

Price Performance

Historical Comparison
ICCC
SRZN

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Share on Social Networks: